{"id":"https://openalex.org/W2093564263","doi":"https://doi.org/10.1007/s12094-014-1206-6","title":"Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K\u2013AKT pathway","display_name":"Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K\u2013AKT pathway","publication_year":2014,"publication_date":"2014-07-24","ids":{"openalex":"https://openalex.org/W2093564263","doi":"https://doi.org/10.1007/s12094-014-1206-6","mag":"2093564263","pmid":"https://pubmed.ncbi.nlm.nih.gov/25060568"},"language":"en","primary_location":{"id":"doi:10.1007/s12094-014-1206-6","doi":"https://doi.org/10.1007/s12094-014-1206-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12094-014-1206-6","pdf_url":null,"source":{"id":"https://openalex.org/S179824187","display_name":"Clinical & Translational Oncology","issn_l":"1699-048X","issn":["1699-048X","1699-3055"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001194399","display_name":"Ahmet Dirican","orcid":"https://orcid.org/0000-0001-6992-9289","observed_orcids":["https://orcid.org/0000-0001-6992-9289"]},"institutions":[{"id":"https://openalex.org/I250383648","display_name":"Izmir K\u00e2tip \u00c7elebi University","ror":"https://ror.org/024nx4843","country_code":"TR","type":"education","lineage":["https://openalex.org/I250383648"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"A. Dirican","raw_affiliation_strings":["Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, 35360, Izmir, Turkey, ahmetdirican@yahoo.com","Izmir Katip Celebi University Atat\u00fcrk Training and Research Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, 35360, Izmir, Turkey, ahmetdirican@yahoo.com","institution_ids":["https://openalex.org/I250383648"]},{"raw_affiliation_string":"Izmir Katip Celebi University Atat\u00fcrk Training and Research Hospital","institution_ids":["https://openalex.org/I250383648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074117573","display_name":"Harika Atmaca","orcid":"https://orcid.org/0000-0002-8459-4373","observed_orcids":["https://orcid.org/0000-0002-8459-4373"]},"institutions":[{"id":"https://openalex.org/I16748637","display_name":"Manisa Celal Bayar University","ror":"https://ror.org/053f2w588","country_code":"TR","type":"education","lineage":["https://openalex.org/I16748637"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"H. Atmaca","raw_affiliation_strings":["Section of Molecular Biology, Department of Biology, Faculty of Science and Arts, Celal Bayar University, Manisa, Turkey","Celal Bayar University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Molecular Biology, Department of Biology, Faculty of Science and Arts, Celal Bayar University, Manisa, Turkey","institution_ids":["https://openalex.org/I16748637"]},{"raw_affiliation_string":"Celal Bayar University","institution_ids":["https://openalex.org/I16748637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052099734","display_name":"Emir Bozkurt","orcid":"https://orcid.org/0000-0003-4703-397X","observed_orcids":["https://orcid.org/0000-0003-4703-397X"]},"institutions":[{"id":"https://openalex.org/I16748637","display_name":"Manisa Celal Bayar University","ror":"https://ror.org/053f2w588","country_code":"TR","type":"education","lineage":["https://openalex.org/I16748637"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"E. Bozkurt","raw_affiliation_strings":["Section of Molecular Biology, Department of Biology, Faculty of Science and Arts, Celal Bayar University, Manisa, Turkey","Celal Bayar University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Molecular Biology, Department of Biology, Faculty of Science and Arts, Celal Bayar University, Manisa, Turkey","institution_ids":["https://openalex.org/I16748637"]},{"raw_affiliation_string":"Celal Bayar University","institution_ids":["https://openalex.org/I16748637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059781939","display_name":"\u00c7i\u011fdem Erten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I250383648","display_name":"Izmir K\u00e2tip \u00c7elebi University","ror":"https://ror.org/024nx4843","country_code":"TR","type":"education","lineage":["https://openalex.org/I250383648"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"C. Erten","raw_affiliation_strings":["Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, 35360, Izmir, Turkey","Izmir Katip Celebi University Atat\u00fcrk Training and Research Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, 35360, Izmir, Turkey","institution_ids":["https://openalex.org/I250383648"]},{"raw_affiliation_string":"Izmir Katip Celebi University Atat\u00fcrk Training and Research Hospital","institution_ids":["https://openalex.org/I250383648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054610146","display_name":"Bur\u00e7ak Karaca","orcid":"https://orcid.org/0000-0003-2638-1625","observed_orcids":["https://orcid.org/0000-0003-2638-1625"]},"institutions":[{"id":"https://openalex.org/I41641357","display_name":"Ege University","ror":"https://ror.org/02eaafc18","country_code":"TR","type":"education","lineage":["https://openalex.org/I41641357"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"B. Karaca","raw_affiliation_strings":["Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Izmir, Turkey","EGE University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Izmir, Turkey","institution_ids":["https://openalex.org/I41641357"]},{"raw_affiliation_string":"EGE University","institution_ids":["https://openalex.org/I41641357"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001231739","display_name":"R\u00fc\u00e7han Uslu","orcid":"https://orcid.org/0000-0002-9584-6134","observed_orcids":["https://orcid.org/0000-0002-9584-6134"]},"institutions":[{"id":"https://openalex.org/I41641357","display_name":"Ege University","ror":"https://ror.org/02eaafc18","country_code":"TR","type":"education","lineage":["https://openalex.org/I41641357"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"R. Uslu","raw_affiliation_strings":["Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Izmir, Turkey","EGE University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Izmir, Turkey","institution_ids":["https://openalex.org/I41641357"]},{"raw_affiliation_string":"EGE University","institution_ids":["https://openalex.org/I41641357"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5001194399"],"corresponding_institution_ids":["https://openalex.org/I250383648"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":11.7732,"has_fulltext":false,"cited_by_count":76,"citation_normalized_percentile":{"value":0.97966172,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"17","issue":"2","first_page":"145","last_page":"151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12750","display_name":"Nigella sativa pharmacological applications","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12750","display_name":"Nigella sativa pharmacological applications","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.09669999778270721,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thymoquinone","display_name":"thymoquinone","score":1.0},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.953000009059906},{"id":"https://openalex.org/keywords/du145-cells","display_name":"DU145 cells","score":0.9750000238418579},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.8149999976158142},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":1.0},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9660000205039978},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.9559999704360962},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5019999742507935},{"id":"https://openalex.org/keywords/nigella-sativa","display_name":"Nigella sativa","score":0.7699999809265137},{"id":"https://openalex.org/keywords/flavonoids","display_name":"flavonoids","score":0.7279999852180481},{"id":"https://openalex.org/keywords/ly294002","display_name":"LY294002","score":0.8790000081062317}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9628385901451111},{"id":"https://openalex.org/C2779034068","wikidata":"https://www.wikidata.org/wiki/Q7799650","display_name":"Thymoquinone","level":3,"score":0.8975054621696472},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8185772895812988},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6935669779777527},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6076206564903259},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5453301668167114},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5389322638511658},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.53571617603302},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5354317426681519},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4750635325908661},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4417988359928131},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4305475950241089},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4208076000213623},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3365118205547333},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33521974086761475},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1040729284286499},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07897719740867615},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.059946537017822266},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016227","descriptor_name":"Benzoquinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12094-014-1206-6","doi":"https://doi.org/10.1007/s12094-014-1206-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12094-014-1206-6","pdf_url":null,"source":{"id":"https://openalex.org/S179824187","display_name":"Clinical & Translational Oncology","issn_l":"1699-048X","issn":["1699-048X","1699-3055"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Oncology","raw_type":"journal-article"},{"id":"pmid:25060568","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25060568","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W188706542","https://openalex.org/W205177961","https://openalex.org/W1480088359","https://openalex.org/W1966517158","https://openalex.org/W1966553997","https://openalex.org/W1970474035","https://openalex.org/W1972912578","https://openalex.org/W1978619135","https://openalex.org/W1985196841","https://openalex.org/W1996497433","https://openalex.org/W2002685287","https://openalex.org/W2035201015","https://openalex.org/W2039171557","https://openalex.org/W2043395027","https://openalex.org/W2062663016","https://openalex.org/W2064426272","https://openalex.org/W2066075559","https://openalex.org/W2071643828","https://openalex.org/W2073100248","https://openalex.org/W2077223675","https://openalex.org/W2077380927","https://openalex.org/W2079621764","https://openalex.org/W2080439368","https://openalex.org/W2088064069","https://openalex.org/W2098103923","https://openalex.org/W2113046540","https://openalex.org/W2114693836","https://openalex.org/W2119068203","https://openalex.org/W2125209555","https://openalex.org/W2134788484","https://openalex.org/W2135468465","https://openalex.org/W2149307190","https://openalex.org/W2154871907","https://openalex.org/W2155591792"],"related_works":["https://openalex.org/W2973601874","https://openalex.org/W4318822773","https://openalex.org/W7171320818","https://openalex.org/W2131365678","https://openalex.org/W3187571009","https://openalex.org/W2142661454","https://openalex.org/W3005755617","https://openalex.org/W2499045702","https://openalex.org/W3127202064","https://openalex.org/W4391470644"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}